Relievant Medsystems achieved the milestone of more than 10,000 patients treated with the Intracept procedure to address vertebrogenic lower back pain.
Relievant Medsystems’ minimally invasive Intracept Procedure is reported to be the only FDA-cleared treatment for the relief of vertebrogenic pain. The same-day, outpatient procedure uses targeted radiofrequency energy to stop the basivertebral nerve from transmitting pain signals from the vertebrae, and takes approximately one hour to perform.
Based on existing data, patients typically experience minimal post-procedure discomfort and a quick recovery. The Intracept Procedure is supported by scientific evidence, including two Level I randomized clinical trials and data showing improvements are sustained more than five years post-procedure.
“The safety and durability of the Intracept Procedure are not only demonstrated by a robust set of clinical data but also by the physicians and patients who have experienced its impact firsthand,” said Tyler Binney, President and CEO of Relievant Medsystems. “Over 5 million people suffer from vertebrogenic pain in the U.S., and we know that these 10,000 patients are the first of many to receive pain relief and potentially realize a better quality of life.”
Relievant Medsystems achieved the milestone of more than 10,000 patients treated with the Intracept procedure to address vertebrogenic lower back pain.
Relievant Medsystems’ minimally invasive Intracept Procedure is reported to be the only FDA-cleared treatment for the relief of vertebrogenic pain. The same-day, outpatient procedure uses...
Relievant Medsystems achieved the milestone of more than 10,000 patients treated with the Intracept procedure to address vertebrogenic lower back pain.
Relievant Medsystems’ minimally invasive Intracept Procedure is reported to be the only FDA-cleared treatment for the relief of vertebrogenic pain. The same-day, outpatient procedure uses targeted radiofrequency energy to stop the basivertebral nerve from transmitting pain signals from the vertebrae, and takes approximately one hour to perform.
Based on existing data, patients typically experience minimal post-procedure discomfort and a quick recovery. The Intracept Procedure is supported by scientific evidence, including two Level I randomized clinical trials and data showing improvements are sustained more than five years post-procedure.
“The safety and durability of the Intracept Procedure are not only demonstrated by a robust set of clinical data but also by the physicians and patients who have experienced its impact firsthand,” said Tyler Binney, President and CEO of Relievant Medsystems. “Over 5 million people suffer from vertebrogenic pain in the U.S., and we know that these 10,000 patients are the first of many to receive pain relief and potentially realize a better quality of life.”
Copy to clipboard 
